Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Global severity
RCT	96 people with seborrhoeic dermatitis of the face; 96% men, mean age 59 years	Change from baseline in total target area score 4 weeks 3.7 with pimecrolimus cream 1% 3.3 with vehicle cream (placebo)	P = 0.191 The difference between groups favoured pimecrolimus on per protocol analysis: for full details see further information on studies		Not significant
Scaling
RCT	96 people with seborrhoeic dermatitis of the face; 96% men, mean age 59 years	Change from baseline in scaling 4 weeks 1.9 with pimecrolimus cream 1% 1.7 with vehicle cream (placebo)	Significance not assessed
Erythema
RCT	96 people with seborrhoeic dermatitis of the face; 96% men, mean age 59 years	Change from baseline in erythema 4 weeks 1.8 with pimecrolimus cream 1% 1.6 with vehicle cream (placebo)	Significance not assessed